Position in LH
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$16,940,280
+$2,408,474 QoQ
Shares Held
60,501
+11.1% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#130
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $560,550,956 across 29 Diagnostics & Research names. LH ranks #10 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
325,602 | $163,243,818 | |
| 2 | DHR |
Danaher Corp /De/
|
426,487 | $81,237,243 | |
| 3 | WAT |
Waters Corp /De/
|
199,677 | $74,886,862 | |
| 4 | NTRA |
Natera, Inc.
|
166,937 | $45,315,048 | |
| 5 | DGX |
Quest Diagnostics Inc
|
143,079 | $30,325,594 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
139,383 | $26,931,583 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
44,772 | $23,569,771 | |
| 8 | ILMN |
Illumina, Inc.
|
111,145 | $19,542,625 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,940,280 | 60,501 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $14,531,806 | 54,465 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $13,323,985 | 53,109 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $14,226,406 | 49,559 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,610,781 | 55,658 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,202,790 | 52,431 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $14,343,048 | 62,546 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $8,534,477 | 38,189 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $7,538,010 | 37,040 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||